Repolar Pharmaceuticals Ltd was founded in 2006. The company researches, develops, produces and markets preparations for the treatment of wound, skin and nail bacterial and fungal inflammations, the effectiveness of which stems from the properties of components refined from the resin of the Finnish forest spruce (Picea abies). The headquarter and production facilities are located in Espoo. The company is a member of the Finnish Family Firms Association.
Repolar Pharmaceuticals Ltd was founded in 2006. The company researches, develops, produces and markets preparations for the treatment of wound, skin and nail bacterial and fungal inflammations, the effectiveness of which stems from the properties of components refined from the resin of the Finnish forest spruce (Picea abies). The headquarter and production facilities are located in Espoo. The company is a member of the Finnish Family Firms Association.